삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

소화기내과 이준혁 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 간질환
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
1998.02 서울대학교 내과학 박사
1992.02 서울대학교 내과학 석사
1988.02 서울대학교 의학과 학사

경력

경력
2021.04 ~현재 삼성서울병원 내과 과장
2021.04 ~현재 성균관대학교 의과대학 내과학교실 주임교수
2009.04 ~현재 성균관대학교 삼성서울병원 교수
2019.04 ~ 2021.03 삼성서울병원 소화기내과 과장
2016.01 ~ 2019.03 삼성서울병원 대외협력실장
2015.03 ~ 2016.01 삼성서울병원 암병원 간암센터장
2012.03 ~ 2015.02 삼성서울병원 국제협력팀장
2003.04 ~ 2009.03 성균관대학교 삼성서울병원 부교수
2002.02 ~ 2003.03 Stanford University 연수 (1년 2개월)
1997.03 ~ 2003.03 성균관대학교 삼성서울병원 조교수
1995.05 ~ 1997.02 삼성서울병원 소화기내과 임상강사
1989.03 ~ 1992.02 서울대학교 병원 레지던트
1988.03 ~ 1989.02 서울대학교 병원 인턴
논문
  • LIVER CANCER 2023 10.1159/000534513 Real-world Data on the Diagnosis, Treatment and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT study Sim, YK; Chong, MC; Gandhi, M; Pokharkar, YM; Zhu, YA; Shi, LM; Lequn, L; Chen, CH; Kudo, M; Lee, JH; Strasser, S; Chanwat, R; Chow, PKH
    View PubMed
  • JHEP REP 2023 10.1016/j.jhepr.2023.100810 Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • LIVER INT 2023 10.1111/liv.15632 Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-36668-2 Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220420 Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • LIVER CANCER 2023 10.1159/000529635 Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220337 Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS
    View PubMed
  • ANN LAB MED 2022 10.3343/alm.2022.42.4.491 The First Case of Clostridium saudiense Bacteremia in a Patient with Hepatocellular Carcinoma Yoon, E; Kim, TY; Heo, WY; Kang, O; Yu, HJ; Lee, JH; Ko, JH; Lee, NY; Huh, HJ
    View PubMed
  • SCAND J GASTROENTERO 2022 10.1080/00365521.2022.2093124 Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development Chang, JI; Sinn, DH; Jeong, WK; Hwang, JA; Won, HY; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • KOREAN J INTERN MED 2022 10.3904/kjim.2021.452 Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea Song, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-11736-1 Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e92 A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients Kim, HJ; Kim, JH; Yeon, JE; Seo, YS; Jang, JW; Cho, YK; Jang, BK; Han, BH; Lee, C; Lee, JH; Yoon, JH; Kim, KM; Kim, MY; Kim, DY; Park, NH; Cho, EY; Lee, JS; Lee, JW; Kim, IH; Song, BC; Lee, BS; Kwon, OS
    View PubMed
  • GENOME MED 2022 10.1186/s13073-021-00995-8 Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY
    View PubMed
  • EUR J GASTROEN HEPAT 2022 10.1097/MEG.0000000000001915 Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase Seong, G; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • SCAND J GASTROENTERO 2021 10.1080/00365521.2021.1988700 Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B Goh, MJ; Kang, W; Kim, KM; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2021 10.1007/s10620-021-07312-8 Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels Chang, JI; Sinn, DH; Cho, H; Kim, S; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J HEPATOCELL CARCINO 2021 10.2147/JHC.S329018 Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study Gandhi, M; Ling, WH; Chen, CH; Lee, JH; Kudo, M; Chanwat, R; Strasser, SI; Xu, Z; Lai, SH; Chow, PKH
    View PubMed
  • J VIRAL HEPATITIS 2021 10.1111/jvh.13572 Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response Na, JE; Sinn, DH; Lee, JH; Jang, HJ; Baek, SY; Kim, KA; Kang, WS; Gwak, GY; Paik, YH; Kim, YJ; Choi, MS; Yoon, JH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOLOGY 2021 10.1002/hep.32034 The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study Park, Y; Sinn, DH; Oh, JH; Goh, MJ; Kim, K; Kang, W; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Gwak, GY
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2021.03.030 Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure Kim, JE; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOL INT 2021 10.1007/s12072-021-10205-7 Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy Oh, JH; Lee, HW; Sinn, DH; Park, JY; Kim, BK; Kim, SU; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • NUTRIENTS 2021 10.3390/nu13031013 Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease Oh1, JH; Lee, JH; Cho, MS; Kim, H; Chun, J; Lee, JH; Yoon, Y; Kang, W
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13306 Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely Cho1, JY; Sohn, W; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, CG
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROINTEST SURG 2019 10.1007/s11605-018-04074-z Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Kim1, JM; Kwon, CHD; Joh, JW; Yoo, H; Kim, K; Sinn, DH; Choi, GS; Lee, JH
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5740-z Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data Yoon1, JS; Song, BG; Lee, JH; Lee, HY; Kim, SW; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, YJ; Lee, JH; Yoon, JH
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CANCER IMMUNOL IMMUN 2019 10.1007/s00262-018-2247-4 Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up Lee1, JH; Lee, JH; Lim, YS; Yeon, JE; Song, TJ; Yu, SJ; Gwak, GY; Kim, KM; Kim, YJ; Lee, JW; Yoon, JH
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • LIVER INT 2018 10.1111/liv.13732 Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • LIVER INT 2018 10.1111/liv.13489 Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • Drug Des Devel Ther 2017 10.2147/DDDT.S149199 Baracle (R) vs Baraclude (R) for 48 weeks in patients with treatment-naive chronic hepatitis B: a comparison of efficacy and safety Kim1, DY; Kim, JH; Tak, WY; Yeon, JE; Lee, JH; Yoon, JH; Lee, YJ; Lee, BS; Han, BH; Lee, HC
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.20529 Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture Yoo1, GS; Park, HC; Il Yu, J; Lim, DH; Cho, WK; Lee, E; Jung, SH; Han, Y; Kim, ES; Lee, SH; Eoh, W; Park, SJ; Chung, SS; Lee, CS; Lee, JH
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17072 Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096 Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
    View PubMed
  • Oncoimmunology 2017 10.1080/2162402X.2017.1328335 Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study Lee1, JH; Tak, WY; Lee, Y; Heo, MK; Song, JS; Kim, HY; Park, SY; Bae, SH; Lee, JH; Heo, J; Kim, KH; Bae, YS; Kim, YJ
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Medicine (Baltimore). 2016 Dec;95(51):e5382. doi: 10.1097/MD.0000000000005382. Nonanatomical resection is comparable with anatomical resection in solitary hepatocellular carcinoma < 5 cm in the right posterior section Kim JM11, Kwon CH, Joh JW, Na BG, Lee KW, Choi GS, Lee JH.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
    View PubMed
  • Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • Clin Transplant. 2016 Apr;30(4):452-60. doi: 10.1111/ctr.12710. Epub 2016 Mar 1. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study Mueller JL11,2, King LY1,2, Johnson KB1,2, Gao T3, Nephew LD4, Kothari D2,5, Simpson MA6, Zheng H7, Wei L8, Corey KE1,2, Misdraji J9, Lee JH10, Lin MV1,2, Gogela NA1,2, Fuchs BC2,8, Tanabe KK2,8, Gordon FD2,6, Curry MP2,5, Chung RT1,2.
    View PubMed
  • World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Br J Surg. 2016 Feb;103(3):276-83. doi: 10.1002/bjs.10048. Epub 2015 Dec 23. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation Kim JM11, Kwon CH1, Joh JW1, Han SB2, Sinn DH3, Choi GS1, Kang ES4, Lee JH3, Kim GS2, Lee SK1.
    View PubMed
  • Radiother Oncol. 2016 Feb;118(2):408-15. doi: 10.1016/j.radonc.2015.11.019. Epub 2016 Jan 28. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study Yu JI11, Park JW2, Park HC3, Yoon SM4, Lim do H1, Lee JH5, Lee HC6, Kim SW7, Kim JH2.
    View PubMed
  • Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(1):e2400. doi: 10.1097/MD.0000000000002400. Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents Shin JH11, Kwon HJ, Jang HR, Lee JE, Gwak GY, Huh W, Jung SH, Lee JH, Kim YG, Kim DJ, Oh HY.
    View PubMed
  • Korean J Intern Med. 2016 Jan;31(1):46-53. doi: 10.3904/kjim.2016.31.1.46. Epub 2015 Dec 28. Feasibility of alpha-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea Ahn DG11, Kim HJ1, Kang H2, Lee HW1, Bae SH3, Lee JH4, Paik YH4, Lee JS5.
    View PubMed
  • Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28. Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16. Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Gastroenterology. 2015 Jun;148(7):1383-91.e6. doi: 10.1053/j.gastro.2015.02.055. Epub 2015 Mar 4. Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma Lee JH11, Lee JH2, Lim YS3, Yeon JE4, Song TJ5, Yu SJ2, Gwak GY1, Kim KM3, Kim YJ2, Lee JW6, Yoon JH7.
    View PubMed
  • J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma Korean Liver Cancer Study Group (KLCSG); National Cancer Center1, Korea (NCC).
    View PubMed
  • PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015. Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11. Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404. Intrahepatic Metastasis is More Risky than Multiple Occurrence in Hepatocellular Carcinoma Patients after Curative Liver Resection Kim JM1, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK.
    View PubMed
  • Am J Surg. 2015 Feb;209(2):391-7. doi: 10.1016/j.amjsurg.2013.06.010. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma Kim JM11, Cho BI1, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim SJ1, Paik SW3, Park CK4.
    View PubMed
  • Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450. Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study Kim JM11, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Korean J Intern Med.?2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients Kim HJ11,?Cho JY1,?Kim YJ1,?Gwak GY1,?Paik YH1,?Choi MS1,?Koh KC1,?Paik SW1,?Yoo BC1,?Lee JH1.
    View PubMed
  • J Surg Oncol. 2014 Dec;110(8):976-81. doi: 10.1002/jso.23772. Epub 2014 Aug 29. Outcomes After Curative Hepatectomy in Patients with Non-B Non-C Hepatocellular Carcinoma And Hepatitis B Virus Hepatocellular Carcinoma From Non-Cirrhotic Liver Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Hepatology. 2014 Nov;60(5):1697-707. doi: 10.1002/hep.27290. Epub 2014 Sep 29. Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial Kudo M11, Han G, Finn RS, Poon RT, Blanc JF, Yan L, Yang J, Lu L, Tak WY, Yu X, Lee JH, Lin SM, Wu C, Tanwandee T, Shao G, Walters IB, Dela Cruz C, Poulart V, Wang JH.
    View PubMed
  • Hepatogastroenterology. 2014 Sep;61(134):1673-6. The Effect of Hepatocellular Carcinoma Bile Duct Tumor Thrombi in Liver Transplantation Kim JM1, Kwon CH, Joh JW, Park JB, Gwak MS, Lee JH, Kim GS, Kim SJ, Lee SK.
    View PubMed
  • Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25. Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.
    View PubMed
  • Hepatogastroenterology. 2014 Sep;61(134):1704-11. Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
    View PubMed
  • J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30. Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12. HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
    View PubMed
  • Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504. Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.
    View PubMed
  • Ann Surg Treat Res. 2014 May;86(5):256-63. doi: 10.4174/astr.2014.86.5.256. Epub 2014 Apr 24. High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients Kim JM11, Park H1, Jang HR2, Park JB1, Kwon CH1, Huh W2, Lee JH2, Kim SJ1, Joh JW1.
    View PubMed
  • World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059. Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation Kim JM11, Kang TW1, Kwon CH1, Joh JW1, Ko JS1, Park JB1, Rhim H1, Lee JH1, Kim SJ1, Paik SW1.
    View PubMed
  • Transplant Proc. 2014 Apr;46(3):726-9. doi: 10.1016/j.transproceed.2013.11.037. Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma Kim JM11, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim GS4, Kim SJ1, Paik SW3, Lee SK1.
    View PubMed
  • Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Ann Surg Treat Res. 2014 Mar;86(3):122-9. doi: 10.4174/astr.2014.86.3.122. Epub 2014 Feb 24. Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A Kim JM11, Kwon CH1, Joh JW1, Park JB1, Lee JH2, Kim GS3, Kim SJ1, Paik SW2.
    View PubMed
  • Ann Surg Oncol. 2014 Feb;21(2):458-65. doi: 10.1245/s10434-013-3302-1. Epub 2013 Oct 17. Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis Kim JM11, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21. Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Liver Int. 2013 Apr;33(4):586-94. doi: 10.1111/liv.12108. Epub 2013 Jan 29. A nationwide seroepidemiology of hepatitis C virus infection in South Korea Kim do Y11, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, Lee D, Suh DJ, Han KH, Park NH, Kang HY, Jung YK, Kim YS, Kim KA, Lee YJ, Lee BS, Yim HJ, Lee HJ, Baik SK, Tak WY, Lee SJ, Chung WJ, Choi SK, Cho EY, Heo J, Kim DJ, Song BC, Kim MW, Lee J, Chae HB, Choi DH, Choi HY, Ki M.
    View PubMed
  • Liver Int.?2013 Feb;33(2):197-202. doi: 10.1111/liv.12023. Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma Min YW11,?Kim J,?Kim S,?Sung YK,?Lee JH,?Gwak GY,?Paik YH,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.
    View PubMed
  • World J Gastroenterol.?2012 Dec 21;18(47):6996-7002. doi: 10.3748/wjg.v18.i47.6996. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures Kim YJ11,?Sinn DH,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.
    View PubMed
  • Gut Liver.?2012 Oct;6(4):520-3. doi: 10.5009/gnl.2012.6.4.520. Epub 2012 Oct 18. A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by Repair Sung YK11,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.
    View PubMed
  • Clin Gastroenterol Hepatol. 2012 Mar;10(3):291-6. doi: 10.1016/j.cgh.2011.09.031. Epub 2011 Oct 20. Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B Kim JH11, Kwon SY, Lee YS, Lee JH, Lee YS, Lee CH.
    View PubMed
  • J Gastroenterol Hepatol.?2012 Feb;27(2):306-12. doi: 10.1111/j.1440-1746.2011.06852.x. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients Kim YJ11,?Cho HC,?Sinn DH,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.
    View PubMed
  • World J Gastroenterol.?2011 Aug 14;17(30):3526-30. doi: 10.3748/wjg.v17.i30.3526. Virological response to adefovir monotherapy and the risk of adefovir resistance Sinn DH11,?Lee HIe,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.
    View PubMed
  • Eur J Gastroenterol Hepatol.?2011 Jan;23(1):51-9. doi: 10.1097/MEG.0b013e3283407158. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score Cho HC11,?Jung HY,?Sinn DH,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Kim SW,?Lee JH.
    View PubMed
  • J Korean Med Sci.?2010 Jan;25(1):54-60. doi: 10.3346/jkms.2010.25.1.54. Epub 2009 Dec 29. Long-term Treatment Outcomes for Autoimmune Hepatitis in Korea Kil JS11,?Lee JH,?Han AR,?Kang JY,?Won HJ,?Jung HY,?Lim HM,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.
    View PubMed
  • J Clin Gastroenterol.?2008 Oct;42(9):974-9. doi: 10.1097/MCG.0b013e318126c154. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices Choi YS11,?Lee JH,?Sinn DH,?Song YB,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.
    View PubMed
  • Hepatogastroenterology.?2008 Mar-Apr;55(82-83):578-81. Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study Kim JH11,?Lee JH,?Park SJ,?Bae MH,?Kim JH,?Kim do Y,?Kim JK,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.
    View PubMed
  • J Clin Gastroenterol. 2001 Apr;32(4):329-32. Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B Choi MS11, Lee JH, Koh KC, Paik SW, Rhee PL, Kim JJ, Rhee JC, Choi KW, Kim SH.
    View PubMed